Myokines for treating cell proliferative and metabolic diseases and disorders
US12252522B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Jan 6, 2023 |
| Grant date | Mar 18, 2025 |
| Priority date | — |
| Expiry date | Jan 6, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compositions comprising myokines and their methods of preparation and use. The disclosed myokine compositions and methods may comprise myokines having a molecular weight of greater than about 10 kDa such as myostatin and metrnl. The disclosed myokine compositions and methods may be utilized for treating and/or preventing cell proliferative and metabolic diseases and disorders. In particular, the disclosed myokine compositions and methods may be utilized for treating and/or preventing cell proliferative and metabolic diseases and disorders, such as cancer, and metabolic diseases and disorders, such as diabetes, non-alcoholic fatty liver disease, and heart disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.